![](/img/cover-not-exists.png)
Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma
Richardson, P. G., Hofmeister, C. C., Raje, N. S., Siegel, D. S., Lonial, S., Laubach, J., Efebera, Y. A., Vesole, D. H., Nooka, A. K., Rosenblatt, J., Doss, D., Zaki, M. H., Bensmaine, A., Herring, JLanguage:
english
Journal:
Leukemia
DOI:
10.1038/s41375-018-0235-5
Date:
September, 2018
File:
PDF, 182 KB
english, 2018